Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Pacific Biosciences of California    P09

Real-time Quote. Real-time Tradegate - 11/20 12:18:44 pm
2.556 EUR   +1.35%
11/02 PACIFIC BIOSCIE : reports 3Q loss
11/02 Pacific Biosciences Appoints Kathy Ordoñez as Chief Commercial Of..
11/02 Pacific Biosciences of California, Inc. Announces Third Quarter 2..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
11/14/2017 11/15/2017 11/16/2017 11/17/2017 11/20/2017 Date
2.389(c) 2.405(c) 2.512(c) 2.522(c) 2.487 Last
0 100 0 160 0 Volume
+0.63% +0.67% +4.45% +0.40% -1.39% Change
More quotes
Financials ($)
Sales 2017 90,3 M
EBIT 2017 -91,4 M
Net income 2017 -94,2 M
Debt 2017 0,60 M
Yield 2017 -
Sales 2018 113 M
EBIT 2018 -79,0 M
Net income 2018 -79,2 M
Finance 2018 0,27 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 3,84x
EV / Sales2018 3,07x
Capitalization 346 M
More Financials
Company
Pacific Biosciences of California, Inc. engages in the research, development and manufacture of sequencing systems for genetic analysis.It operates through the following geographical segments: North America, Europe, and Asia.It offers deoxyribonucleic acid sequencing, third generation sequencing... 
More about the company
Surperformance© ratings of Pacific Biosciences of Cal
Trading Rating : Investor Rating :
More Ratings
Latest news on PACIFIC BIOSCIENCES OF CAL
11/15 PACIFIC BIOSCIENCES OF CALIFORNIA : DNA sequencer maintenance
11/03 PACIFIC BIOSCIENCES OF CALIFORNIA : Appoints Kathy Ordoez as Chief Commercial Of..
11/02 PACIFIC BIOSCIENCES OF CALIFORNIA : reports 3Q loss
11/02 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Change in Directors or Principal Officers..
11/02 PACIFIC BIOSCIENCES OF CALIFORNIA : Management's Discussion and Analysis of Fina..
11/02 Pacific Biosciences Appoints Kathy Ordoñez as Chief Commercial Officer
11/02 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Results of Operations and Financial Condi..
11/02 Pacific Biosciences of California, Inc. Announces Third Quarter 2017 Financia..
10/21 Pacific Biosciences of California, Inc. Third Quarter 2017 Financial Results ..
10/16 Recent Projects Highlight Success of SMRT Sequencing for Characterizing Struc..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
11/13 SONOVA : misses sales, profit forecasts as U.S. overhaul bites
11/12 FISHER & PAYKEL HEALTHCARE : & Paykel says UK court rules rival Resmed's patent ..
10/30DJROYAL PHILIPS : Correction to Philips Share Buyback Article
10/30DJROYAL PHILIPS : Philips Launches EUR150 Million Share Buyback for Employee Stock..
10/23 European stocks hold firm as banks, Spanish shares fall
More sector news : Advanced Medical Equipment & Technology - NEC
Chart PACIFIC BIOSCIENCES OF CAL
Duration : Period :
Pacific Biosciences of Cal Technical Analysis Chart | P09 | US69404D1081 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 5,03 $
Spread / Average Target 69%
EPS Revisions
Managers
NameTitle
Michael W. Hunkapiller Executive Chairman, President & CEO
Susan K. Barnes CFO, Principal Accounting Officer & Executive VP
Stephen W. Turner Chief Technical Officer & Vice President
James Michael Phillips Senior Vice President-Research & Development
Jonas Korlach Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
PACIFIC BIOSCIENCES OF CALIFORNIA-31.02%346
THERMO FISHER SCIENTIFIC INC.34.78%75 857
DANAHER19.86%64 900
INTUITIVE SURGICAL85.67%43 977
BOSTON SCIENTIFIC CORPORATION30.65%38 807
ROYAL PHILIPS14.34%36 778